Dr. Jagdish Hiremath - Achieving 24 hours BP Control to work towards ZERO CV Event

Large visit-to-visit systolic BP variability in patients with CKD predicts a higher risk of death and nonfatal cardiovascular events independent of underlying BP levels.

Large visit-to-visit systolic BP variability in patients with CKD predicts a higher risk of death and nonfatal cardiovascular events independent of underlying BP levels. Hypertension is the most relevant treatable risk factor for the prevention of CV events and progression to kidney failure in patients with CKD.